The Weight Loss Pill That Could Disrupt a $32 Billion Industry

A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.

Don't miss out on the "next Ozempic" >>>

Pamela G. Bailey net worth and biography

Pamela Bailey Biography and Net Worth

Director of Integer

Pamela G. Bailey served as President and Chief Executive Officer of The Grocery Manufacturers Association, a Washington, D.C. based trade association from January 2009 until she retired in August 2018. From April 2005 until January 2009, she was President and Chief Executive Officer of the Personal Care Products Council. Ms. Bailey served as President and Chief Executive Officer of Advanced Medical Technology Association (AdvaMed), the world's largest association representing the medical technology industry, from June 1999 to April 2005. From 1970 to 1999 she served in the White House, the Department of Health and Human Services and other public and private organizations with responsibilities for health care public policy. Ms. Bailey formerly served as a director of Albertsons, Inc., MedCath Corporation, and The National Food Laboratory, Inc. From 2010 to 2014, she served on the Advisory Committee for Trade Policy and Negotiations (ACTPN), the principal trade advisory committee for the Office of the U.S. Trade Representative. Ms. Bailey serves on the following Committees of the Board of Directors of Integer Holdings Corporation: Corporate Governance and Nominating Committee (Chair) and Compensation and Organization Committee.

What is Pamela G. Bailey's net worth?: The estimated net worth of Pamela G. Bailey is at least $6.45 million as of November 5th, 2019. Ms. Bailey owns 56,990 shares of Integer stock worth more than $6,447,849 as of May 8th. This net worth approximation does not reflect any other investments that Ms. Bailey may own. Learn More about Pamela G. Bailey's net worth.
How do I contact Pamela G. Bailey?: The corporate mailing address for Ms. Bailey and other Integer executives is 5830 Granite Parkway Suite 1150, Plano TX, 75024. Integer can also be reached via phone at (214) 618-5243 and via email at [email protected]. Learn More on Pamela G. Bailey's contact information.
Has Pamela G. Bailey been buying or selling shares of Integer?: Pamela G. Bailey has not been actively trading shares of Integer during the last quarter. Most recently, Pamela G. Bailey sold 7,231 shares of the business's stock in a transaction on Monday, December 6th. The shares were sold at an average price of $84.52, for a transaction totalling $611,164.12. Learn More on Pamela G. Bailey's trading history.
Who are Integer's active insiders?: Integer's insider roster includes Pamela Bailey (Director), Anthony Borowicz (SVP), Joseph Dziedzic (CEO), Joseph Flanagan (EVP), Jean Hobby (Director), Carter Houghton (Insider), Bill Sanford (Director), and Donald Spence (Director). Learn More on Integer's active insiders.
Are insiders buying or selling shares of Integer?: In the last twelve months, insiders at the medical equipment provider sold shares 3 times. They sold a total of 11,625 shares worth more than $1,010,036.25. The most recent insider tranaction occured on April, 30th when VP Tommy P Thomas sold 1,500 shares worth more than $171,000.00. Insiders at Integer own 2.0% of the company. Learn More about insider trades at Integer.
Information on this page was last updated on 4/30/2024.

Pamela G. Bailey Insider Trading History at Integer

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/6/2021	Sell	7,231	$84.52	$611,164.12
11/5/2019	Sell	7,446	$76.75	$571,480.50	56,990
11/20/2018	Sell	5,767	$83.16	$479,583.72	53,562
11/17/2017	Sell	5,590	$47.01	$262,785.90	41,907

Pamela G. Bailey Buying and Selling Activity at Integer

Integer Company Overview

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Today's Range

Now: $113.14

$112.04

$113.43

50 Day Range

MA: $114.56

$108.26

$123.34

2 Week Range

Now: $113.14

$69.40

$123.99

Volume

250,443 shs

Average Volume

338,297 shs

Market Capitalization

$3.79 billion

P/E Ratio

39.15

Dividend Yield

N/A

Beta

1.12